Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

New antiepileptic drugs.

¹Comprehensive Epilepsy Center, Columbia University College of Physicians and Surgeons, 710 West 168th Street, New York, NY 10032, USA. cwb11@columbia.edu

Current Neurology and Neuroscience Reports

|March 20, 2002

Summary

Choosing the right antiepileptic drug (AED) is complex. Recent evidence shows newer AEDs are effective in monotherapy and have broad action, with adverse effects aiding selection for epilepsy patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Pregabalin increases slow-wave sleep and may improve attention in patients with partial epilepsy and insomnia.

Epilepsy & behavior : E&B·2012

Same author

Long-term association between seizure outcome and depression after resective epilepsy surgery.

Neurology·2011

Same author

Cross-sensitivity of skin rashes with antiepileptic drug use.

Neurology·2008

Same author

Comparison and predictors of rash associated with 15 antiepileptic drugs.

Neurology·2007

Same author

Position statement on the coverage of anticonvulsant drugs for the treatment of epilepsy.

Neurology·2007

Same author

Health care costs decline after successful epilepsy surgery.

Neurology·2007

Area of Science:

Pharmacology
Neurology
Clinical Therapeutics

Background:

The increasing number of approved antiepileptic drugs (AEDs) complicates the selection of optimal treatment for epilepsy.
Distinguishing between various AEDs based on efficacy, spectrum of action, and adverse effects is crucial for effective patient management.

Purpose of the Study:

To review the most recent information on antiepileptic drugs, focusing on those approved within the last decade.
To provide clinicians with updated evidence to aid in selecting the most appropriate AED for individual epilepsy patients.

Main Methods:

Literature review of recent studies and drug approvals.
Analysis of Food and Drug Administration (FDA) indications and clinical trial data.
Evaluation of drug efficacy in monotherapy and spectrum of action.

Main Results:

Despite potentially limited FDA-approved indications, all reviewed AEDs demonstrate utility in monotherapy for epilepsy treatment.
Many newer AEDs possess broader spectrums of action than initially recognized.
Distinct adverse effect profiles can serve as a key differentiator between various antiepileptic agents.

Conclusions:

Clinicians should be familiar with the latest data on AEDs to optimize epilepsy treatment.
Understanding the nuances of efficacy, spectrum, and side effects is essential for personalized antiepileptic drug selection.
All antiepileptic drugs, including newer agents, can be valuable tools in managing epilepsy.

Related Experiment Videos